Provided by Tiger Trade Technology Pte. Ltd.

Pulse Biosciences

53.11
-1.3200-2.43%
Pre-market: 53.110.00000.00%04:47 EDT
Volume:664.33K
Turnover:35.03M
Market Cap:3.79B
PE:-45.18
High:56.61
Open:54.50
Low:50.32
Close:54.43
52wk High:58.90
52wk Low:12.56
Shares:71.32M
Float Shares:20.65M
Volume Ratio:0.74
T/O Rate:3.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1756
EPS(LYR):-1.0800
ROE:-78.49%
ROA:-44.34%
PB:38.07
PE(LYR):-49.18

Loading ...

Pulse Biosciences Launches $75 Million ATM Equity Program

TIPRANKS
·
Aug 07

Pulse Biosciences Q2 Net Loss Widens, Cash Position Strengthens

Reuters
·
Aug 07

Pulse Biosciences Q2 EPS $(0.36), Inline, Sales $434.000K Miss $533.333K Estimate

Benzinga Earnings
·
Aug 07

Pulse Biosciences Q2 Income from Operations USD -25.272 Million

Reuters
·
Aug 07

Pulse Biosciences - Establishes New $75 Mln Atm Facility, Maintains $125 Mln Shelf Registration

THOMSON REUTERS
·
Aug 07

Pulse Biosciences - Targets Ce Mark Submission in H2 2026, Potential Approval by Mid-2027

THOMSON REUTERS
·
Aug 07

Pulse Biosciences Q2 EPS USD -0.36

THOMSON REUTERS
·
Aug 07

Pulse Biosciences Inc Expected to Post a Loss of 36 Cents a Share - Earnings Preview

Reuters
·
Aug 05

Pulse Biosciences management to meet with BTIG

TIPRANKS
·
Aug 05

Earning Preview: Pulse Biosciences this quarter’s revenue is expected to increase by 0%, and institutional views are bullish

Earnings Agent
·
Jul 31

Canaccord Genuity Keeps Their Buy Rating on Pulse Biosciences (PLSE)

TIPRANKS
·
Jul 30

Pulse Biosciences Schedules Earnings Conference Call, Webcast

Reuters
·
Jul 29

Oppenheimer Adjusts Pulse Biosciences PT to $35 From $30, Maintains Outperform Rating

MT Newswires Live
·
Jul 28

Pulse Biosciences Inc. : Oppenheimer Raises Target Price to $35 from $30

THOMSON REUTERS
·
Jul 28

Pulse Biosciences Schedules Second-quarter Results Conference Call

Reuters
·
Jul 22

Pulse Biosciences Grants Inducement Stock Options for 9,000 Shares at USD 25.89 Each

Reuters
·
Jul 16

Pulse Biosciences Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 16

Pulse Biosciences (PLSE) Is Up 5.0% After Joining S&P Healthcare Equipment Index Is Sentiment Shifting?

Simply Wall St.
·
Jun 22

Did Warrant Redemptions Just Reframe Pulse Biosciences' (PLSE) Cardiac Ablation Investment Narrative?

Simply Wall St.
·
Jun 13

Pulse Biosciences Shareholders Approve Board and Auditor Slate

TIPRANKS
·
Jun 13